Influenza vaccines, also known as flu shots, are vaccines that protect against influenza. A new version of the vaccine is developed twice a year as the influenza virus rapidly changes. Most provide modest to high protection against influenza; however, each year this varies. Evidence in adults over 65 years old is poor. They decrease the number of missed days of work by a half day on average. Vaccinating children may protect those around them.
The global Injection Influenza Vaccine market was valued at US$ 7635 million in 2023 and is anticipated to reach US$ 10970 million by 2030, witnessing a CAGR of 5.3% during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Injection Influenza Vaccine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Injection Influenza Vaccine.
Report Scope
The Injection Influenza Vaccine market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Injection Influenza Vaccine market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Injection Influenza Vaccine manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Sanofi
CSL
GSK
Viatris
AstraZeneca
Hualan Bio
Changchun Institute of Biological
Sinovac
Jiangsu GDK
KM Biologics
Segment by Type
Trivalent Influenza Vaccine
Quadrivalent Influenza Vaccine
Segment by Application
6 Months to 3 Years
> 3 Years
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Injection Influenza Vaccine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Injection Influenza Vaccine in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Injection Influenza Vaccine Market Overview
1.1 Product Overview and Scope of Injection Influenza Vaccine
1.2 Injection Influenza Vaccine Segment by Type
1.2.1 Global Injection Influenza Vaccine Market Value Comparison by Type (2024-2030)
1.2.2 Trivalent Influenza Vaccine
1.2.3 Quadrivalent Influenza Vaccine
1.3 Injection Influenza Vaccine Segment by Application
1.3.1 Global Injection Influenza Vaccine Market Value by Application: (2024-2030)
1.3.2 6 Months to 3 Years
1.3.3 > 3 Years
1.4 Global Injection Influenza Vaccine Market Size Estimates and Forecasts
1.4.1 Global Injection Influenza Vaccine Revenue 2019-2030
1.4.2 Global Injection Influenza Vaccine Sales 2019-2030
1.4.3 Global Injection Influenza Vaccine Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Injection Influenza Vaccine Market Competition by Manufacturers
2.1 Global Injection Influenza Vaccine Sales Market Share by Manufacturers (2019-2024)
2.2 Global Injection Influenza Vaccine Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Injection Influenza Vaccine Average Price by Manufacturers (2019-2024)
2.4 Global Injection Influenza Vaccine Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Injection Influenza Vaccine, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Injection Influenza Vaccine, Product Type & Application
2.7 Injection Influenza Vaccine Market Competitive Situation and Trends
2.7.1 Injection Influenza Vaccine Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Injection Influenza Vaccine Players Market Share by Revenue
2.7.3 Global Injection Influenza Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Injection Influenza Vaccine Retrospective Market Scenario by Region
3.1 Global Injection Influenza Vaccine Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Injection Influenza Vaccine Global Injection Influenza Vaccine Sales by Region: 2019-2030
3.2.1 Global Injection Influenza Vaccine Sales by Region: 2019-2024
3.2.2 Global Injection Influenza Vaccine Sales by Region: 2025-2030
3.3 Global Injection Influenza Vaccine Global Injection Influenza Vaccine Revenue by Region: 2019-2030
3.3.1 Global Injection Influenza Vaccine Revenue by Region: 2019-2024
3.3.2 Global Injection Influenza Vaccine Revenue by Region: 2025-2030
3.4 North America Injection Influenza Vaccine Market Facts & Figures by Country
3.4.1 North America Injection Influenza Vaccine Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Injection Influenza Vaccine Sales by Country (2019-2030)
3.4.3 North America Injection Influenza Vaccine Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Injection Influenza Vaccine Market Facts & Figures by Country
3.5.1 Europe Injection Influenza Vaccine Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Injection Influenza Vaccine Sales by Country (2019-2030)
3.5.3 Europe Injection Influenza Vaccine Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Injection Influenza Vaccine Market Facts & Figures by Country
3.6.1 Asia Pacific Injection Influenza Vaccine Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Injection Influenza Vaccine Sales by Country (2019-2030)
3.6.3 Asia Pacific Injection Influenza Vaccine Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Injection Influenza Vaccine Market Facts & Figures by Country
3.7.1 Latin America Injection Influenza Vaccine Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Injection Influenza Vaccine Sales by Country (2019-2030)
3.7.3 Latin America Injection Influenza Vaccine Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Injection Influenza Vaccine Market Facts & Figures by Country
3.8.1 Middle East and Africa Injection Influenza Vaccine Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Injection Influenza Vaccine Sales by Country (2019-2030)
3.8.3 Middle East and Africa Injection Influenza Vaccine Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Injection Influenza Vaccine Sales by Type (2019-2030)
4.1.1 Global Injection Influenza Vaccine Sales by Type (2019-2024)
4.1.2 Global Injection Influenza Vaccine Sales by Type (2025-2030)
4.1.3 Global Injection Influenza Vaccine Sales Market Share by Type (2019-2030)
4.2 Global Injection Influenza Vaccine Revenue by Type (2019-2030)
4.2.1 Global Injection Influenza Vaccine Revenue by Type (2019-2024)
4.2.2 Global Injection Influenza Vaccine Revenue by Type (2025-2030)
4.2.3 Global Injection Influenza Vaccine Revenue Market Share by Type (2019-2030)
4.3 Global Injection Influenza Vaccine Price by Type (2019-2030)
5 Segment by Application
5.1 Global Injection Influenza Vaccine Sales by Application (2019-2030)
5.1.1 Global Injection Influenza Vaccine Sales by Application (2019-2024)
5.1.2 Global Injection Influenza Vaccine Sales by Application (2025-2030)
5.1.3 Global Injection Influenza Vaccine Sales Market Share by Application (2019-2030)
5.2 Global Injection Influenza Vaccine Revenue by Application (2019-2030)
5.2.1 Global Injection Influenza Vaccine Revenue by Application (2019-2024)
5.2.2 Global Injection Influenza Vaccine Revenue by Application (2025-2030)
5.2.3 Global Injection Influenza Vaccine Revenue Market Share by Application (2019-2030)
5.3 Global Injection Influenza Vaccine Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Sanofi
6.1.1 Sanofi Corporation Information
6.1.2 Sanofi Description and Business Overview
6.1.3 Sanofi Injection Influenza Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Sanofi Injection Influenza Vaccine Product Portfolio
6.1.5 Sanofi Recent Developments/Updates
6.2 CSL
6.2.1 CSL Corporation Information
6.2.2 CSL Description and Business Overview
6.2.3 CSL Injection Influenza Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.2.4 CSL Injection Influenza Vaccine Product Portfolio
6.2.5 CSL Recent Developments/Updates
6.3 GSK
6.3.1 GSK Corporation Information
6.3.2 GSK Description and Business Overview
6.3.3 GSK Injection Influenza Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.3.4 GSK Injection Influenza Vaccine Product Portfolio
6.3.5 GSK Recent Developments/Updates
6.4 Viatris
6.4.1 Viatris Corporation Information
6.4.2 Viatris Description and Business Overview
6.4.3 Viatris Injection Influenza Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Viatris Injection Influenza Vaccine Product Portfolio
6.4.5 Viatris Recent Developments/Updates
6.5 AstraZeneca
6.5.1 AstraZeneca Corporation Information
6.5.2 AstraZeneca Description and Business Overview
6.5.3 AstraZeneca Injection Influenza Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.5.4 AstraZeneca Injection Influenza Vaccine Product Portfolio
6.5.5 AstraZeneca Recent Developments/Updates
6.6 Hualan Bio
6.6.1 Hualan Bio Corporation Information
6.6.2 Hualan Bio Description and Business Overview
6.6.3 Hualan Bio Injection Influenza Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Hualan Bio Injection Influenza Vaccine Product Portfolio
6.6.5 Hualan Bio Recent Developments/Updates
6.7 Changchun Institute of Biological
6.6.1 Changchun Institute of Biological Corporation Information
6.6.2 Changchun Institute of Biological Description and Business Overview
6.6.3 Changchun Institute of Biological Injection Influenza Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Changchun Institute of Biological Injection Influenza Vaccine Product Portfolio
6.7.5 Changchun Institute of Biological Recent Developments/Updates
6.8 Sinovac
6.8.1 Sinovac Corporation Information
6.8.2 Sinovac Description and Business Overview
6.8.3 Sinovac Injection Influenza Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Sinovac Injection Influenza Vaccine Product Portfolio
6.8.5 Sinovac Recent Developments/Updates
6.9 Jiangsu GDK
6.9.1 Jiangsu GDK Corporation Information
6.9.2 Jiangsu GDK Description and Business Overview
6.9.3 Jiangsu GDK Injection Influenza Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Jiangsu GDK Injection Influenza Vaccine Product Portfolio
6.9.5 Jiangsu GDK Recent Developments/Updates
6.10 KM Biologics
6.10.1 KM Biologics Corporation Information
6.10.2 KM Biologics Description and Business Overview
6.10.3 KM Biologics Injection Influenza Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.10.4 KM Biologics Injection Influenza Vaccine Product Portfolio
6.10.5 KM Biologics Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Injection Influenza Vaccine Industry Chain Analysis
7.2 Injection Influenza Vaccine Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Injection Influenza Vaccine Production Mode & Process
7.4 Injection Influenza Vaccine Sales and Marketing
7.4.1 Injection Influenza Vaccine Sales Channels
7.4.2 Injection Influenza Vaccine Distributors
7.5 Injection Influenza Vaccine Customers
8 Injection Influenza Vaccine Market Dynamics
8.1 Injection Influenza Vaccine Industry Trends
8.2 Injection Influenza Vaccine Market Drivers
8.3 Injection Influenza Vaccine Market Challenges
8.4 Injection Influenza Vaccine Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
Sanofi
CSL
GSK
Viatris
AstraZeneca
Hualan Bio
Changchun Institute of Biological
Sinovac
Jiangsu GDK
KM Biologics
*If Applicable.